Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease:
![Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/08/EMJ-Gastroenterol.-2018-Suppl-2-Takeda.jpg)
Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal
![European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine](https://kongres-magazine.eu/wp-content/uploads/2017/02/IMG_4737-800x600.jpg)